EC ever use among women of reproductive age: 0.5% (DHS 2008-09)
EC knowledge among women of reproductive age: 10.1% (DHS 2008-09)
Contraceptive Use: 40.8% (DHS 2008-09, ever use of a modern method among women of reproductive age)
Registered LNG-EC products:
- NorLevo 1.5mg* - Available only with prescription
- Pill 72* - Available only with prescription
- Pregnon - Available only with prescription
- Revoke 72* - Available only with prescription
Registered UPA-EC products:
- ellaOne* - Available directly from pharmacist without prescription (i.e. BTC)
Products marked with * have been approved by a stringent regulatory authority, such as the WHO Prequalification Programme, the US Food and Drug Administration, the European Medicines Agency, or other.
Where at least one type of ECP is available: Public sector clinics, Pharmacies, IPPF-affiliated system
Age restrictions for accessing ECPs: No data available
Legal/regulatory documents in which EC is included: No data available
Other relevant information: Madagascar's Essential Medicines List does not include EC.
EC distributed via IPPF outlets (<500 in 2012).
In Madagascar, the lowest cadre of health workers allowed to sell/dispense ECPs in the public sector is midwives. The lowest cadre of health workers allowed to sell/dispense ECPs in the private sector is midwives. (Data as of 2013.) (USAID/DELIVER, Contraceptive Security Indicators, 2013)
In 2013, EC was procured by the government. No stock-outs were reported at the central level (JSI/Deliver data).